This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Gastrointestinal (GI) symptoms associated with COVID-19, like nausea, vomiting and diarrhoea, can be challenging to treat. While the exact cause of these symptoms is still unknown, there are some treatments available to help reduce their severity and frequency. In general, the goal of GI symptom treatment is to manage nausea, vomiting and/or diarrhoea, while also providing adequate nutrition and hydration. To reduce nausea, doctors may recommend anti-vomiting medications, such as ondansetron. Ondansetron works by blocking signals from the brain to the stomach, which can reduce nausea. Additionally, anti-diarrheal medications, such as loperamide, can help reduce the severity and frequency of diarrhoea. It is important to stay hydrated, even if nausea and vomiting make it difficult. An oral rehydration solution can help replenish electrolytes and other essential minerals. In addition to medications, lifestyle modifications, such as avoiding spicy foods, may help reduce GI symptoms. To ensure you are getting adequate nutrition and hydration, your doctor may recommend a high-calorie and nutrient-rich diet. This could include foods like eggs, peanut butter, yogurt, and fortified cereals.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States